New EU “transparency” measures give member states the power to block vaccine exports if manufacturers can’t meet contractual obligations.

Mice with severed spinal cords walk again after gene therapy.

Everything cell + gene therapy – in five minutes.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen.

We sit down with the British Generics Manufacturers Association's Warwick Smith.

Big Data opens the door to even smarter cell therapies.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

What factors are driving pharma's move towards digital marketing?

The advanced medicine field is progressing at breakneck speed, but we must move forward with the needs of the patient in mind.